Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with NivolumabJunko Tanizaki, Kazuhiko Nakagawa, Yasushi Nakamura et al.|Journal of Thoracic Oncology|2017Cited by 227
Preventive effects of etodolac, a selective cyclooxygenase‐2 inhibitor, on cancer development in extensive metaplastic gastritis, a <i>Helicobacter pylori</i> ‐negative precancerous lesionKimihiko Yanaoka, Masao Ichinose, Masashi Oka et al.|International Journal of Cancer|2009Cited by 40